Literature DB >> 19322554

[What is migraine?].

M Schürks1.   

Abstract

Migraine is a multifactorial and heterogeneous disorder. Diagnostic criteria have been established by the International Headache Society, however these are only supportive in terms of definition. The pathophysiology involves neuronal and vascular phenomena. The former is supported by the cortical spreading depression being the aura correlate and by brainstem and hypothalamic activation during the pain phase; the latter is suggested by the association between migraine and cardiovascular disease and findings of pathological vasoreactivity and endothelial dysfunction. Triptans and calcitonin gene-related peptide receptor antagonists show only a relative migraine-specific action; up to 30% of patients are nonresponders. Despite a clear genetic component, the discovery of specific genes for common forms of migraine remains elusive. Electrophysiological studies consistently indicate a characteristic "dyshabituation" concurring with clinical features of altered sensory perception. The age- and sex-specific pattern along with the effect of external factors on the course of migraine argue in favor of the involvement of epigenetic mechanisms. Knowledge about migraine is still limited, which hampers a definition.

Entities:  

Mesh:

Year:  2009        PMID: 19322554     DOI: 10.1007/s00115-009-2704-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  28 in total

1.  An integrated epigenetic and genetic approach to common human disease.

Authors:  Hans T Bjornsson; M Daniele Fallin; Andrew P Feinberg
Journal:  Trends Genet       Date:  2004-08       Impact factor: 11.639

2.  Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.

Authors:  Hayrunnisa Bolay; Uwe Reuter; Andrew K Dunn; Zhihong Huang; David A Boas; Michael A Moskowitz
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

3.  Brain stem activation in spontaneous human migraine attacks.

Authors:  C Weiller; A May; V Limmroth; M Jüptner; H Kaube; R V Schayck; H H Coenen; H C Diener
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

Review 4.  The epidemiology of migraine.

Authors:  Richard B Lipton; Marcelo E Bigal
Journal:  Am J Med       Date:  2005-03       Impact factor: 4.965

5.  Familial risk of migraine: a population-based study.

Authors:  W F Stewart; J Staffa; R B Lipton; R Ottman
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

6.  Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.

Authors:  T W Ho; L K Mannix; X Fan; C Assaid; C Furtek; C J Jones; C R Lines; A M Rapoport
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

7.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

Review 8.  Serotonin and migraine: biology and clinical implications.

Authors:  E Hamel
Journal:  Cephalalgia       Date:  2007-11       Impact factor: 6.292

Review 9.  [Cortical dysbalance in the brain in migraineurs--hyperexcitability as the result of sensitisation?].

Authors:  A Stankewitz; A May
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

Review 10.  Migraine: a complex genetic disorder.

Authors:  Maija Wessman; Gisela M Terwindt; Mari A Kaunisto; Aarno Palotie; Roel A Ophoff
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.